Peptidyl-prolyl isomerases: a new twist to transcription
AUTOR(ES)
Shaw, Peter E.
FONTE
Oxford University Press
RESUMO
Peptidyl-prolyl isomerases (PPIs) catalyse the cis–trans isomerisation of peptide bonds N-terminal to proline residues in polypeptide chains. They have roles in the folding of newly synthesised proteins and in the function of the immune system. In addition, members of the parvulin-like family of PPIs have been implicated in cell cycle control. Their activity is directed by the prior phosphorylation of target proteins in both yeast and mammalian cells. More recent data have illustrated that they may also influence other nuclear events. This review examines PPI activity in the context of eukaryotic transcriptional regulation. The findings are consistent with a two-step model of conformational control, in which the outcome depends on the transcription factor involved.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1084152Documentos Relacionados
- Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription
- Cyclophilin A Peptidyl-Prolyl Isomerase Activity Promotes Zpr1 Nuclear Export
- A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor.
- Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A
- Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection.
